DAX24.853 ±-0,0%Est506.011 -0,4%MSCI World4.343 -0,1%Top 10 Crypto8,3200 -2,6%Nas22.597 -2,0%Bitcoin55.575 -0,3%Euro1,1870 ±0,0%Öl67,55 -3,0%Gold4.946 +0,5%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Siemens Energy ENER6Y Siemens 723610 Mercedes-Benz Group (ex Daimler) 710000 SAP 716460 Deutsche Telekom 555750 Rheinmetall 703000 NVIDIA 918422 BASF BASF11 Gerresheimer A0LD6E Amazon 906866 Lufthansa 823212 Microsoft 870747 Allianz 840400 Bayer BAY001 DroneShield A2DMAA
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX letztlich kaum bewegt -- US-Börsen rot -- Mercedes-Benz: Gewinneinbruch -- Siemens erhöht Ergebnisprognose -- TKMS, Deutsche Börse, DroneShield, Birkenstock, Micron, Palantir, Fastly im Fokus
Top News
Analysten: Gold und Silber werden immer mehr zu einem Spekulationsobjekt Analysten: Gold und Silber werden immer mehr zu einem Spekulationsobjekt
Batteriezellenproduktion: Tesla schafft entscheidenden Durchbruch - Treiber für die Aktie? Batteriezellenproduktion: Tesla schafft entscheidenden Durchbruch - Treiber für die Aktie?
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Poxel SA Aktie

Kaufen
Verkaufen
Poxel SA Aktien-Sparplan
0,2865 EUR +0,0010 EUR +0,35 %
BMN
0,2825 EUR +0,0005 EUR +0,18 %
PAR
Poxel SA jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.15,12 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA14M04

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINFR0012432516

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolPXXLF

Poxel SA Aktien News

DatumMeistgelesen
BusinesswirePoxel Reports Financial Results for First Half 2024 and Provides an Update on its Financial Position and Outlook
BusinesswirePoxel Reports Cash and Revenue for the Third Quarter and Nine Months 2024 and Provides Corporate Update
BusinesswirePoxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG® Royalties for USD 50 million
Wer­bungPoxel SA-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
BusinesswirePoxel Reports Revenue for the Second Quarter and First Half 2024 and Provides Corporate Update
BusinesswireSumitomo Pharma and Poxel Announce Topline Results from Post-Marketing Clinical Study on TWYMEEG® for the Treatment of Type 2 Diabetes in Japan
BusinesswirePoxel Provides an Update on Its Financial Position for the Second Quarter and First Half of 2024 and Announces the Rescheduling of Its Annual General Meeting
BusinesswirePoxel Reports Revenue for the First Quarter 2024 and Provides Corporate Update
BusinesswirePoxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results Release
BusinesswirePoxel to Report Its 2023 Annual Results by the End of April 2024
BusinesswirePoxel Reports Cash and Revenue for the Full Year 2023 and Provides Corporate Update
BusinesswirePoxel Announces its Financial Calendar for 2024
BusinesswirePoxel Provides Corporate Update
BusinesswirePoxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023
BusinesswirePoxel Announces its Participation at Upcoming Investor Conferences
BusinesswirePoxel Announces its Participation at Upcoming Scientific Conference
BusinesswirePoxel Reports Financial Results for First Half 2023 and Provides a Corporate Update
BusinesswirePoxel to Report 2023 First Half-Year Results and host a video conference on September 26, 2023
BusinesswirePoxel Reports Cash and Revenue for the Second Quarter and First Half 2023 and Provides Corporate Update
BusinesswirePoxel Announces Upcoming Participation at the H.C. Wainwright 2nd Annual Kidney Conference
BusinesswirePoxel, winner of the 2023 edition of the I-nov contest
BusinesswirePoxel Announces the Approval of a Prospectus for the Listing of New Shares on Euronext Paris
BusinesswirePoxel Announces Results from June 21, 2023 Ordinary Annual and Extraordinary General Meeting
BusinesswirePoxel Announces its Participation at Patient Association Conferences in Adrenoleukodystrophy
BusinesswirePoxel Reports Cash and Revenue for the First Quarter 2023 and Provides Corporate Update
BusinesswirePoxel Announces Notice of Its Annual General Meeting to Be Held on June 21, 2023
BusinesswirePoxel Announces TWYMEEG® (Imeglimin) Fiscal Year 2022 Sales
BusinesswirePoxel Announces Upcoming Participation at the JMP Securities Life Science Conference
BusinesswirePoxel Announces Multiple TWYMEEG® (Imeglimin) Abstracts Accepted for Oral Presentation
BusinesswirePoxel Reports Financial Results for Full Year 2022 and Provides Corporate Update
BusinesswirePoxel Announces Cash Runway Extended Through Q2 2025 Based upon Debt Restructuring Agreement and New Equity-linked Financing Facility
BusinesswirePoxel Announces Upcoming Participation at Evercore ISI’s NASH Renaissance Event
BusinesswirePoxel Announces Publication of Positive Phase 2 Results from Phase 2 NASH Trial (DESTINY-1) for PXL065 in Journal of Hepatology
BusinesswirePoxel Announces Publication in Kidney International of PXL770 Preclinical Results in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
BusinesswirePoxel Reports Cash and Revenue for the Full Year 2022 and Provides Corporate Update

Poxel SA News

Poxel SA News: auf dieser Seite finden Sie alle Poxel SA News und Nachrichten zur Poxel SA Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Poxel SA News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Poxel SA News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.